News

DCHFA Invests in Affordable Housing with Barnaby & 7th Phase II

DCHFA Invests in Affordable Housing with Barnaby & 7th Phase II

DCHFA's New Initiative for Affordable Housing

Washington, D.C. – The District of Columbia Housing Finance Agency (DCHFA) has recently made waves with its commitment to enhancing affordable living options within the city. This venture involves the issuance of $63 million in tax-exempt bonds and substantial underwriting efforts, leading to the development of 229 affordable apartments as part of the Barnaby & 7th project. Such significant investment marks a pivotal moment in addressing the housing needs of residents in the District.

Investment in Community Development

This ambitious project, often referred to as Barnaby & 7th Phase II, follows the successful completion of Phase I, which saw the construction of 169 affordable units in 2022. These developments embody DCHFA's mission to create vibrant, supportive environments for the community. Christopher E. Donald, Executive Director/CEO of DCHFA, emphasized the Agency's dedication to providing healthy, affordable homes. He expressed pride in the ongoing collaboration with Gilbane Development and other partners involved in this transformative project.

Collaborative Efforts in Modernizing Neighborhoods

The Barnaby & 7th initiative stands as a testament to the power of community and collaboration. In a strategic move, residents of the former Belmont Crossing exercised their Tenant Opportunity to Purchase Act (TOPA) rights, playing a crucial role in shaping the redevelopment plan that aligns with their needs. This level of engagement fosters a sense of ownership among residents, ensuring that the new housing developments reflect the desires of the community.

The Vision of Barnaby & 7th: Phase II Details

The project will see the construction of four new buildings, with a total investment reaching approximately $135 million. These buildings will feature a variety of apartment sizes, including efficiency units, one-, two-, and three-bedroom apartments. This diversity aims to meet the needs of families, particularly those earning 30, 50, and 80 percent of the area median income.

Support for Vulnerable Populations

A significant highlight of this phase is the commitment to provide 100 percent permanent supportive housing for formerly homeless residents. This initiative not only addresses the housing crisis but also includes on-site support services, catering to the multifaceted needs of these individuals.

Funding and Financial Support

DCHFA is not alone in this endeavor. The project has also received additional financing from the DC Department of Housing and Community Development, including a $42.9 million loan from the Housing Production Trust Fund. This collaboration underscores the essential role of public and private sectors working together to enhance affordable housing accessibility.

The Impact of DCHFA’s Role

For over 45 years, the DCHFA has served as an S&P AA- rated issuer, committed to advancing housing priorities within Washington, D.C. Its mission revolves around transforming lives by investing in affordable housing and neighborhood development. By selecting the most efficient sources of capital to finance housing initiatives, DCHFA aims to create pathways for D.C. residents to thrive.

Looking Ahead: The Future of Housing in D.C.

This ongoing investment in affordable housing not only contributes to the immediate needs of the community but also sets the foundation for longer-term neighborhood revitalization. As developments like Barnaby & 7th Phase II continue to unfold, they pave the way for a brighter future for all residents and demonstrate DCHFA’s unwavering commitment to enhancing the quality of life in the District.

Frequently Asked Questions

What does the Barnaby & 7th Phase II project entail?

The project involves the construction of 229 affordable apartments, funded primarily by DCHFA's investment through bonds and tax credit equity.

Who are the key developers involved in this project?

The key developers include Gilbane Development Company, MED Developers, Equity Plus Manager LLC, and Housing Help Plus.

How will the project support vulnerable residents?

One building will provide 100 percent permanent supportive housing for formerly homeless residents, along with on-site support services to aid their transition.

What is the financial backing for this project?

The project has received $63 million in tax-exempt bonds from DCHFA and a $42.9 million loan from the DC Department of Housing and Community Development.

How does DCHFA play a role in affordable housing?

DCHFA issues tax-exempt mortgage revenue bonds and provides low-cost financing to developers to help create affordable housing solutions in Washington, D.C.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 249

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 61

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 307

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 138

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 203

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 76

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 48

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 149

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 41

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 482

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Abeona Therapeutics' ZEVASKYN Receives FDA Approval, a New Hope

Updated Category News Views 147

A Revolutionary Breakthrough for Epidermolysis Bullosa In an incredible achievement for the EB community, Abeona Therapeutics has received FDA approval for ZEVASKYN, which is poised to change the landscape for treating Recessive Dystrophic Epidermolysis Bullosa (RDEB). This marks a historic moment as the third FDA-approved treatment for RDEB and the first autologous,...

Continue Reading
Zero Candida Reaches Major Milestone with ZC-001 Device Development

Updated Category News Views 127

Zero Candida Marks Milestone with ZC-001 Prototype Production Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) has achieved a remarkable milestone in its quest to revolutionize women's health. The company recently announced the commencement of prototype production for its groundbreaking therapeutic device, ZC-001, designed specifically for the treatment of...

Continue Reading
Bitcoin's Future and Market Dynamics: Insights from a Veteran Trader

Updated Category News Views 86

Cautious Optimism for Bitcoin and Other Cryptocurrencies Pseudonymous veteran trader DonAlt expresses a cautious outlook on leading cryptocurrencies like Bitcoin, Ethereum, and Dogecoin. His insights on market trends reveal an intriguing perspective for investors in these digital assets. Current Market Situation DonAlt has recently shared his thoughts on the performance...

Continue Reading
Alibaba Settles for $433.5 Million in Shareholder Lawsuit

Updated Category News Views 220

Alibaba Reaches Settlement in Lawsuit Alibaba (NYSE: BABA), China’s leading e-commerce powerhouse, has recently taken a significant step in addressing legal challenges by agreeing to pay $433.5 million to settle a class-action lawsuit in the United States. This lawsuit, brought forth by investors, accused Alibaba of engaging in monopolistic practices. The company's...

Continue Reading
Class Action Alert: Telix Pharmaceuticals Lawsuit Overview

Updated Category News Views 174

Understanding the Telix Pharmaceuticals Class Action In a significant development, investors of Telix Pharmaceuticals Limited are currently facing a class action lawsuit. This initiative, spearheaded by Bronstein, Gewirtz & Grossman LLC, invites those affected by substantial losses in their investments to take action. The law firm is renowned for its dedication in...

Continue Reading